Mad Men's Hendricks named the face of the LATISSE Wishes Challenge

Share this article:
Mad Men's Hendricks named the face of the LATISSE Wishes Challenge
Mad Men's Hendricks named the face of the LATISSE Wishes Challenge

Emmy-nominated actress Christina Hendricks, of Mad Men fame, has signed on as the spokesperson for the LATISSE Wishes Challenge, co-launched by Allergan, LATISSE's manufacturer, and the Make-a-Wish Foundation. For the second year running, the pharma company and the non-profit have teamed up to raise money on behalf of the foundation, with this year's goal of raising $500,000 to grant a wish in every Make-A-Wish chapter across the country.

“I've always felt my lashes were short and thin, and in my profession, I wear a lot of false lashes and makeup, which take a toll. So when LATISSE became available, I was curious to learn more,” said Hendricks in a statement. “LATISSE is also a brand that contributes to children, and I couldn't think of a better cause to support than the Make-A-Wish Foundation.”

Consumers can participate in the Challenge by donating a minimum of $20 to the Make-a-Wish Foundation through the campaign's website. LATISSE will double all donations up to $250,000 until November 30 of this year. For extra incentive, the first 10,000 participants to commit to the minimum donation will receive a LATISSE free trial certificate, which they can then discuss the benefits of with their doctor.

"Allergan is proud to continue its commitment to the Make-A-Wish Foundation,” said David Pyott, Chairman of the Board, President and CEO of Allergan, in a statement. “In just two years, LATISSE and the women across the country who use it have raised nearly $1.5 million to help the Make-A-Wish Foundation grant children's wishes. Women appreciate supporting a brand that gives back and that may also provide a solution for themselves. Through the LATISSE Wishes Challenge, women will join Hendricks to support a wonderful cause and learn more about LATISSE to see if it is right for them."

Share this article:

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union